Adimab, LLC

Adimab, LLC

Adimab, LLC

Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.
Founded
2007
Raised
$32.1M
Follow us
Alexa global traffic share
Latest funding Show all
$8,200,000
Venture capital (Series D) - 2010
Borealis Ventures Google Ventures Polaris Partners +2
Team Size
50+
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Adimab, LLC makes some noise.